# OnCo record jazz (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/jazz/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "jazz" ;
  schema:name "Jazz Pharmaceuticals"@en ;
  schema:description "Jazz Pharmaceuticals, based in Dublin, sells zanidatamab (Ziihera), a HER2-targeting antibody, outside Asia for biliary tract and gastro-oesophageal cancer, alongside Rylaze, Zepzelca (lurbinectedin) and CPX-351 for acute myeloid leukaemia. Whether zanidatamab can grow from a rare bile duct indication into gastric cancer is its open question."@en ;
  schema:url <https://onco.cc/companies/jazz/>, <https://www.jazzpharma.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Jazz_Pharmaceuticals> ;
  owl:sameAs <http://www.wikidata.org/entity/Q16255113> ;
  schema:citation <https://www.jazzpharma.com> ;
  schema:addressCountry "IE" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/zanidatamab/>, <https://onco.cc/drugs/crisantaspase/> ;
  onco:trials <https://onco.cc/trials/nct06435429/>, <https://onco.cc/trials/nct05734066/>, <https://onco.cc/trials/nct07102381/>, <https://onco.cc/trials/nct07459634/>, <https://onco.cc/trials/nct06695845/>, <https://onco.cc/trials/nct07282587/> .